These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17436344)

  • 1. Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors.
    Pakkala M; Hekim C; Soininen P; Leinonen J; Koistinen H; Weisell J; Stenman UH; Vepsäläinen J; Närvänen A
    J Pept Sci; 2007 May; 13(5):348-53. PubMed ID: 17436344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of peptides specifically modulating the activity of KLK2 and KLK3.
    Koistinen H; Närvänen A; Pakkala M; Hekim C; Mattsson JM; Zhu L; Laakkonen P; Stenman UH
    Biol Chem; 2008 Jun; 389(6):633-42. PubMed ID: 18627344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides.
    Hekim C; Riipi T; Weisell J; Närvänen A; Koistinen R; Stenman UH; Koistinen H
    Biol Chem; 2010 Apr; 391(4):475-9. PubMed ID: 20180640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
    Laxmikanthan G; Blaber SI; Bernett MJ; Scarisbrick IA; Juliano MA; Blaber M
    Proteins; 2005 Mar; 58(4):802-14. PubMed ID: 15651049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
    Hess S; Ovadia O; Shalev DE; Senderovich H; Qadri B; Yehezkel T; Salitra Y; Sheynis T; Jelinek R; Gilon C; Hoffman A
    J Med Chem; 2007 Nov; 50(24):6201-11. PubMed ID: 17983214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
    Swedberg JE; Nigon LV; Reid JC; de Veer SJ; Walpole CM; Stephens CR; Walsh TP; Takayama TK; Hooper JD; Clements JA; Buckle AM; Harris JM
    Chem Biol; 2009 Jun; 16(6):633-43. PubMed ID: 19549601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel peptide inhibitors of human kallikrein 2.
    Hekim C; Leinonen J; Närvänen A; Koistinen H; Zhu L; Koivunen E; Väisänen V; Stenman UH
    J Biol Chem; 2006 May; 281(18):12555-60. PubMed ID: 16527822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational and biochemical analysis of the cyclic peptides which modulate serine protease activity.
    Pakkala M; Jylhäsalmi A; Wu P; Leinonen J; Stenman UH; Santa H; Vepsäläinen J; Peräkylä M; Närvänen A
    J Pept Sci; 2004 Jul; 10(7):439-47. PubMed ID: 15298179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity.
    Guo S; Skala W; Magdolen V; Briza P; Biniossek ML; Schilling O; Kellermann J; Brandstetter H; Goettig P
    J Biol Chem; 2016 Jan; 291(2):593-604. PubMed ID: 26582203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma.
    Luo LY; Shan SJ; Elliott MB; Soosaipillai A; Diamandis EP
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):742-50. PubMed ID: 16467084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
    Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
    Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of peptides as protease inhibitors and stimulators.
    Koistinen H; Hekim C; Wu P; Närvänen A; Stenman UH
    Methods Mol Biol; 2014; 1088():147-58. PubMed ID: 24146402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.
    Makovitzki A; Fink A; Shai Y
    Cancer Res; 2009 Apr; 69(8):3458-63. PubMed ID: 19351852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6).
    Fernández IS; Ständker L; Mägert HJ; Forssmann WG; Giménez-Gallego G; Romero A
    J Mol Biol; 2008 Apr; 377(5):1488-97. PubMed ID: 18329042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition profiles of human tissue kallikreins by serine protease inhibitors.
    Luo LY; Jiang W
    Biol Chem; 2006 Jun; 387(6):813-6. PubMed ID: 16800745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of marinostatin, a serine protease inhibitor isolated from a marine organism.
    Taichi M; Yamazaki T; Kawahara K; Motooka D; Nakamura S; Harada S; Teshima T; Ohkubo T; Kobayashi Y; Nishiuchi Y
    J Pept Sci; 2010 Jul; 16(7):329-36. PubMed ID: 20552565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Heterocyclohexanone-based inhibitors of the serine protease plasmin.
    Sanders TC; Seto CT
    J Med Chem; 1999 Jul; 42(15):2969-76. PubMed ID: 10425106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tissue kallikreins: the cancer biomarker family.
    Paliouras M; Borgono C; Diamandis EP
    Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.